Axonics News

Axonics | 10-Q: Q2 2024 Earnings Report

Aug 1 16:14 ET

Axonics | 8-K: Axonics Reports Second Quarter 2024 Financial Results

Aug 1 16:10 ET

Axonics | 4: Statement of changes in beneficial ownership of securities-Officer COHEN RAYMOND W

Jul 25 19:34 ET

Axonics | 8-K: Axonics Reports First Quarter 2024 Financial Results

Apr 30 16:51 ET

Axonics | 10-Q: Q1 2024 Earnings Report

Apr 30 16:35 ET

Axonics | 10-K/A: Annual report (Amendment)

Apr 29 16:46 ET

Axonics | 8-K: Current report

Apr 4 08:00 ET

Axonics | 8-K: Current report

Mar 25 16:04 ET

Axonics | DEFA14A: Others

Mar 7 17:26 ET

Axonics | 10-K: FY2023 Annual Report

Feb 29 14:19 ET

Axonics | 8-K: Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Feb 28 16:10 ET

Axonics | DEFM14A: Definitive proxy statement relating to merger or acquisition

Feb 22 08:01 ET

Axonics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(10.38%)

Feb 13 17:09 ET

Axonics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(2.322%),Abigail P. Johnson(2.322%)

Feb 12 12:05 ET

Axonics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(10.710%),Abigail P. Johnson(10.710%)

Feb 9 08:39 ET

Axonics | PREM14A: Preliminary proxy statements relating to merger or acquisition

Feb 7 14:34 ET

Axonics | 4: Statement of changes in beneficial ownership of securities-Officer Sama Rinda

Feb 2 18:02 ET

Axonics | 4: Statement of changes in beneficial ownership of securities-Officer Noblett Karen

Feb 2 18:01 ET

Axonics | 4: Statement of changes in beneficial ownership of securities-Officer Woock John

Feb 2 18:01 ET

Axonics | 4: Statement of changes in beneficial ownership of securities-Officer Ford Alfred J Jr

Feb 2 18:01 ET